OpenAlex
PricingAboutJobs
Log inGet started
Work

An analysis of the attrition of drug candidates from four major pharmaceutical companies

HTML

Year: 2015
Type: review
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd4609
Authors: Michael J. Waring, John Arrowsmith, Andrew R. Leach, Paul D. Leeson, Sam Mandrell, Robert M. Owen, Garry Pairaudeau, William D. Pennie, Stephen D. Pickett, Jibo Wang, Owen Wallace, Alex Weir
Institutions: AstraZeneca (United Kingdom), Thomson Reuters (United Kingdom), GlaxoSmithKline (United Kingdom), Pfizer (United Kingdom), Eli Lilly (United States)
Language: English

Topic: Computational Drug Discovery Methods
Subfield: Drug Discovery
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: drug attrition, small molecule drug candidates, physicochemical properties, clinical failure, drug safety, compound optimization, oral medication, pharmaceutical industry
SDG: Good health and well-being

Open Access status: green

Funder: Pfizer
OpenAlex ID: W1663154925
FWCI: 11.37
Cites: 27
Cited by: 1,668
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms